Advanced Filter

Filter by Group

Filter by Market Availability

Displaying all 2 drugs
Lumacaftor is a drug used in combination with DB08820 as the fixed dose combination product Orkambi for the management of Cystic Fibrosis (CF) in patients aged 6 years and older. Cystic Fibrosis is an autosomal recessive disorder caused by one of several different mutations in the gene for the Cystic...
Approved
Matched Synonyms: … Lumacaftor
Matched Name: … Lumacaftor
Matched Description: … Results from clinical trials indicated that treatment with Orkambi (lumacaftor/ivacaftor) results in ... Ivacaftor is manufactured and distributed by Vertex Pharmaceuticals. ... [A20302] Lumacaftor improves CF symptoms and underlying disease pathology by aiding the conformational …
Matched Categories: … ivacaftor and lumacaftor
Ivacaftor (also known as Kalydeco or VX-770) is a drug used for the management of Cystic Fibrosis (CF). It is manufactured and distributed by Vertex Pharmaceuticals. It was approved by the Food and Drug Administration on January 31, 2012 , and by Health Canada in late 2012. Ivacaftor is administered...
Approved
Matched Synonyms: … Ivacaftor
Matched Name: … Ivacaftor
Matched Description: … [L6841] Ivacaftor is administered as a monotherapy and also administered in combination with other drugs ... Ivacaftor (also known as Kalydeco or VX-770) is a drug used for the management of Cystic Fibrosis (CF ... [A20302] Prior to the development of ivacaftor, management of CF primarily involved therapies for …
Matched Categories: … ivacaftor and lumacaftor ... ivacaftor and tezacaftor ... ivacaftor, tezacaftor and elexacaftor ... ivacaftor
Displaying all 2 drugs